FCM
XGN icon

FourWorld Capital Management’s Exagen XGN Stock Holding History

FourWorld Capital Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32M Buy
439,950
+166,950
+61% +$646K 0.67% 19
2025
Q4 		$1.66M Buy
273,000
+46,000
+20% +$419K 1.35% 13
2025
Q3 		$2.49M Buy
227,000
+18,473
+9% +$164K 3.94% 8
2025
Q2 		$1.46M Buy
+208,527
New +$1.27M 0.98% 13

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

FourWorld Capital Management's XGN Position: Q1 2026 in Review

FourWorld Capital Management increased its Exagen (XGN) stake by 61% in Q1 2026, buying an estimated $646K and bringing the position to 439,950 shares worth $1.32M. The position accounts for 0.67% of the portfolio, ranked #19.

FourWorld Capital Management first reported a position in XGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.49M in Q3 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • FourWorld Capital Management held 439,950 shares of Exagen worth $1.32M as of Q1 2026.
  • FourWorld Capital Management bought 166,950 Exagen shares in Q1 2026, an estimated $646K.
  • Exagen made up 0.67% of FourWorld Capital Management's portfolio in Q1 2026, its #19 holding.
  • FourWorld Capital Management first reported a position in Exagen in Q2 2025 and has held it in 4 quarters since.
  • FourWorld Capital Management's Exagen position peaked at $2.49M in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on FourWorld Capital Management's 13F filing for Q1 2026, filed 15 May 2026.